期刊文献+

Pharmaceutical compounds in aquatic environment in China: locally screening and environmental risk assessment

Pharmaceutical compounds in aquatic environment in China: locally screening and environmental risk assessment
原文传递
导出
摘要 An environmental risk assessment was performed for pharmaceutical compounds present in the aquatic environment of China. Predicted environmental concentration (PEC) of the compounds were calculated according to European Medicines Evaluation Agency (EMEA) guidelines. Available ecotoxicological data compromised by applying a very conservative assessment factor (AF) were employed to calculate the predicted noeffect concentration (PNEC). The screening principle and the risk assessment were based on risk quotient (RQ), which derived from the PEC and related PNEC values. PEC results indicated that all the compounds except sulfadimethoxine and levocamitine, should carry out phase II risk assessment in EMEA guideline. RQ values suggested that more than 36 pharmaceuticals may be imposed health threats to the aquatic environment; especially the antibiotic therapeutic class including amoxicillin, sulfasalazine, trimethoprim, oxytetracycline and erythromycin showed high RQ values. These substances with high RQ value (RQ≥ 1) were regarded as top- priority pharmaceuticals for control in the aquatic environment of China. However, the antibiotic substances which had low risk quotient (RQ 〈 1), should be reassessed by its potentially induced resistance under low concentration in future. An environmental risk assessment was performed for pharmaceutical compounds present in the aquatic environment of China. Predicted environmental concentration (PEC) of the compounds were calculated according to European Medicines Evaluation Agency (EMEA) guidelines. Available ecotoxicological data compromised by applying a very conservative assessment factor (AF) were employed to calculate the predicted noeffect concentration (PNEC). The screening principle and the risk assessment were based on risk quotient (RQ), which derived from the PEC and related PNEC values. PEC results indicated that all the compounds except sulfadimethoxine and levocamitine, should carry out phase II risk assessment in EMEA guideline. RQ values suggested that more than 36 pharmaceuticals may be imposed health threats to the aquatic environment; especially the antibiotic therapeutic class including amoxicillin, sulfasalazine, trimethoprim, oxytetracycline and erythromycin showed high RQ values. These substances with high RQ value (RQ≥ 1) were regarded as top- priority pharmaceuticals for control in the aquatic environment of China. However, the antibiotic substances which had low risk quotient (RQ 〈 1), should be reassessed by its potentially induced resistance under low concentration in future.
出处 《Frontiers of Environmental Science & Engineering》 SCIE EI CAS CSCD 2015年第3期394-401,共8页 环境科学与工程前沿(英文)
基金 This work was supported by the National Natural Science Foundation of China (Grant No. 41301572) Tsinghua Univcrsity- Vcolia Environnmcnt Joint Research Center for Advanced Environmental Technology.
关键词 pharmaceuticals aquatic environment risk assessment aquatic toxicity risk quotient pharmaceuticals, aquatic environment, risk assessment, aquatic toxicity, risk quotient
  • 相关文献

参考文献1

二级参考文献23

  • 1Terries T A, Stumpf M, Mueller J, et al. Behavior and occurrence of estrogens in municipal sewage treatment plants-Ⅰ. Investigations in Germany, Canada and Brazil. Sci Total Environ, 1999, 225:81-90.
  • 2Ternes T A, Kreckel P, Mueller J. Behaviour and occurrence of estrogens in municipal sewage treatment plants-Ⅱ. Aerobic batch experiments with activated sludge. Sci Total Environ, 1999, 225:91-99.
  • 3Castiglioni S, Bagnati R, Calamari D, et al. A multiresidue analytical method using solid-phase extraction and high-pressure liquid chromatography tandem mass spectrometry to measure pharmaceuticals of different therapeutic classes in urban wastewaters. J Chromatogr A, 2005, 1092:206-215.
  • 4Kim S D, Cho J, Kim I S, et al. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Res, 2007, 41:1013-1021.
  • 5Desbrow C, Routledge E J, Brighty G C, et al. Identification of estrogenic chemicals in STP effluent. 1. Chemical fractionation and in-vitro biological screening. Environ Sci Technol, 1998, 32:1549-1558.
  • 6Hashimoto T, Murakami T. Removal and degradation characteristics of natural and synthetic estrogens by activated sludge in batch experiments. Water Res, 2009, 43:573-582.
  • 7Carballa M, Omil F, Lema J M, et al. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res, 2004, 38:2918-2926.
  • 8Kolpin D W, Furlong E T, Meyer M T, et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: A National reconnaissance. Environ Sci Technol, 2004, 36:1202-1211.
  • 9Boyd G R, Reemtsma H, Grimm D A, et al. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Sci Total Environ, 2003, 311: 135-149.
  • 10Zhang S, Zhang Q, Darisaw S, et al. Simultaneous quantification of polycyclic aromatic hydrocarbons (PAHs), polychlorinated biphenyls (PCBs), and pharmaceuticals and personal care products (PPCPs) in Mississippi river water, in New Orleans, Louisiana, USA. Chemosphere, 2007, 66:1057-1069.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部